Synonyms: ACT-179811 | ACT179811
Compound class:
Synthetic organic
Comment: Cadazolid (ACT-179811) is a quinolonyl-oxazolidinone (quinoxolidinone) antibacterial with Gram-positive activity. It targets the bacterial protein synthesis machinery by binding to the peptidyl transferase centre (PTC) of the ribosome [1].
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
1-cyclopropyl-6-fluoro-7-[4-[[2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenoxy]methyl]-4-hydroxypiperidin-1-yl]-4-oxoquinoline-3-carboxylic acid |
International Nonproprietary Names | |
INN number | INN |
9377 | cadazolid |
Synonyms |
ACT-179811 | ACT179811 |
Database Links | |
Specialist databases | |
Antibiotic DB | Cadazolid |
Other databases | |
CAS Registry No. | 1025097-10-2 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL3707376 |
GtoPdb PubChem SID | 405560208 |
PubChem CID | 44242317 |
RCSB PDB Ligand | JJH |
Search Google for chemical match using the InChIKey | XWFCFMXQTBGXQW-GOSISDBHSA-N |
Search Google for chemicals with the same backbone | XWFCFMXQTBGXQW |
Search PubMed clinical trials | cadazolid |
Search PubMed titles | cadazolid |
Search PubMed titles/abstracts | cadazolid |
UniChem Compound Search for chemical match using the InChIKey | XWFCFMXQTBGXQW-GOSISDBHSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | XWFCFMXQTBGXQW-GOSISDBHSA-N |